Chief Operating Officer
From 2007 to 2017 Mr. McLendon served as Chief Operating Officer for Passport Systems; founded by a team of MIT technologists to develop and commercialize nuclear resonance fluorescence technology (“NRF”), from 1999 through 2006 Mr. McLendon was the President of Epion Corporation, a developer and manufacturer of atomic scale processing equipment for semiconductor and other microelectronic applications. From 1993 until 1998, he was President and Chief Executive Officer of Sight Resource Corporation, a provider of comprehensive eye care services including corrective eye surgery. From 1991 through 1993, he was Vice President and Chief Financial Officer of Ibis Technology Corporation, a developer and manufacturer of SIMOX silicon-on-insulator material for semiconductor devices. From 1986 through 1990, he was Vice President and Chief Financial Officer of Summit Technology, Inc., a provider of laser vision correction equipment and services. From 1983 through 1985, he was Vice President and Chief Financial Officer of Zymet Corporation, a developer of industrial ion beam processing equipment. Mr. McLendon has a BS in Accounting from Bentley College
Chief Financial Officer
From 2007 to 2017 Mr. Garcia served as Chief Financial Officer for Passport Systems. From 1997 to 2006, Mr. Garcia was the CFO of Epion Corporation, a developer and manufacturer of atomic scale semiconductor processing equipment and other microelectronic applications. Prior to Epion, Mr. Garcia spent nine years at Summit Technology, a provider of laser vision correction equipment and services in ophthalmology, ultimately serving as Vice President of Operations for the company’s vision centers. Mr. Garcia began his career in the high technology practice at KPMG Peat Marwick. He holds an MBA from the Wharton School at The University of Pennsylvania and a BS in Accounting from Fairfield University. He is also a certified public accountant.
Joe Khoury, Ph.D
Chief Science Officer
Dr. Khoury has extensive experience in the medical device and tissue engineering field and over 20 years of experience in cellular and molecular biology techniques to elucidate complex mechanisms and functions underlying several disease areas. In 2009 Dr. Khoury joined Exogenesis Corporation as its Director of Cell and Molecular Biology and prior to that he held the position of Senior Scientist of Cell and Molecular Biology at Histogenics Corp. He received his Ph.D. from the Dept. of Medicine at McGill University and held the position of Postdoctoral Fellow at Harvard Medical School in the Dept. of Urology at Children’s Hospital Boston, and Instructor in Anesthesia at Brigham and Women’s Hospital. Joe’s experience in cellular and molecular biology has been instrumental in the development of ANAB technology and he will continue in his role at Exogenesis while providing scientific guidance and project management to Vallum.
Chief Technical Officer
Prior to joining Exogenesis in 2009 as its Director of Product Development, Mike had 15 years of experience in managing the development, manufacturing, global deployment and support of leading edge high value technology capital equipment production systems. He held management positions with Tokyo Electron Epion, Epion Corp. and Eaton Corp. Mike has been instrumental in the development of ANAB technology and will continue in his role at Exogenesis while providing technical guidance and project management to Vallum.